In their new Forefront article, @DusetzinaS@AutumnZuckerman @NancyKeatingMD and Haiden A. Huskamp of @VUmedicine, @VUMC_Spec_Pharm, and @harvardmed argue that the Medicare Prescription Payment Plan may have the unintended consequence of "surprise" bills. https://t.co/7hdcpRue00
Important work from @DusetzinaS, @autumnzuckerman and Megan Schneider in @JAMAInternalMed on alternative funding programs, which is one of those topics that a lot more people should be tracking on.
Specialty pharmacists @VUMChealth are using an often overlooked SmartForm reporting tool in the Epic system to streamline data reporting in the center’s HCV clinic. https://t.co/JBlIqvvruL @Rx_Specialty#NASPAnnual#ThisIsNASP#HCV
Investigators @VUMC_Spec_Pharm identified patients who were nonadherent to their medications and developed interventions that yielded significant improvements in compliance. https://t.co/Wnr8kFowIg @AutumnZuckerman@ASHPOfficial @JOANNSTUBBINGS
A new case series and lit review in OFID addresses crushing and splitting direct-acting antivirals for hepatitis C virus treatment in patients unable to swallow tablets: https://t.co/HNLSHMV0KH
#IDSAJournals@PaulSaxMD@DrJLi @vumc_spec_pharm @KristenWhelche3@AutumnZuckerman
@ASHPOfficial provided groundbreaking research around defining an HSSP. It is clear the integrated pharmacy practice model provides the highest level of patient care across the continuum of care
The first @ASHPOfficial survey of health-system specialty pharmacies offered insights into the concerns of specialty pharmacists and provided an opportunity for professionals in the field to outline a potential future for specialty pharmacy.
Learn more: https://t.co/gnsAFxK7uP
Are you interested in expanding the research program at your health-system specialty pharmacy? Check out this excellent guide published by @AutumnZuckerman et al in @AJHPOfficial.
https://t.co/dnb3sgTj6h
@DrugChannels @VUMC_MD @amcporg Dr. Fein, I agree and would welcome an independent study of HSSP vs. non-integrated model on these types of TAT metrics. Improving patient access to appropriate therapy is of highest priority in our field.